Health Care & Life Sciences » Pharmaceuticals | Zeria Pharmaceutical Co. Ltd.

Zeria Pharmaceutical Co. Ltd. | Income Statement

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Sales/Revenue
61,997
61,013
62,475
64,860
64,578
61,824
Cost of Goods Sold (COGS) incl. D&A
18,348
18,521
17,930
18,169
18,342
17,753
Gross Income
43,649
42,491
44,545
46,691
46,236
44,071
SG&A Expense
36,854
30,837
39,983
42,150
41,405
40,334
EBIT
6,790
2,679
4,566
4,542
4,830
3,737
Unusual Expense
102
435
273
319
199
1,526
Non Operating Income/Expense
847
1,763
1,243
958
1,132
143
Interest Expense
243
206
290
267
195
200
Pretax Income
7,309
3,820
5,262
4,921
5,577
5,221
Income Tax
2,035
1,262
1,730
1,345
1,394
1,757
Consolidated Net Income
5,274
2,558
3,532
3,576
4,183
3,464
Net Income
5,277
2,558
3,513
3,544
4,158
3,454
Net Income After Extraordinaries
5,277
2,558
3,513
3,544
4,158
3,454
Net Income Available to Common
5,277
2,558
3,513
3,544
4,158
3,454
EPS (Basic)
115.01
48.15
66.15
66.73
80.72
69.56
Basic Shares Outstanding
46
53
53
53
52
50
EPS (Diluted)
115.01
48.15
66.15
66.73
80.72
69.56
Diluted Shares Outstanding
46
53
53
53
52
50
EBITDA
9,415
5,385
7,685
8,336
8,670
7,471
Other Operating Expense
5
8,975
4
-
-
-
Non-Operating Interest Income
18
19
16
7
9
14
Minority Interest Expense
3
-
19
32
25
10

About Zeria Pharmaceutical Co.

View Profile
Address
10-11 Nihonbashi Kobuna-cho
Tokyo Tokyo 103
Japan
Employees -
Website http://www.zeria.co.jp
Updated 07/08/2019
Zeria Pharmaceutical Co., Ltd. engages in the manufacture, sale, import and export of pharmaceutical products. It also develops and distributes agricultural and industrial chemicals, and reagents. It operates through the following segments: Ethical Pharmaceuticals, Consumer Healthcare, and Others.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.